Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen and Kidney Function in Ultramarathon Runners
NCT02272725Phase 3Completed
- Sponsor
- Stanford University
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in pain and inflammation, sponsored by Stanford University. Primary endpoint: Acute Kidney Injury at 18 hours. Started Mar 2015; status: completed.
02
Drugs
ibuprofen
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT02272725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02272725.